NDC 47426-302-06 - ZYNRELEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 47426-302
- Requested NDC
- 47426-302-06
- Package NDCs from labels
- 47426-302-06, 47426-302-04, 47426-302-02
- Manufacturer
- Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
- Effective date
- 2026-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ZYNRELEF | Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions | 2026-04-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 47426-302-02 | ZYNRELEF | 1 in 1 KIT | SOLUTION | 1 | 16 | |
| 47426-302-04 | ZYNRELEF | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 47426-302-06 | ZYNRELEF | 10.5 mL in 1 VIAL, SINGLE-DOSE | SOLUTION | 10.5 | 16 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| meloxicam | MELOXICAM | A-S Medication Solutions | 11984306-9b71-4c2a-81bc-8942966810be | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | PHOENIX RX LLC | 3ff222f1-3fe2-9591-e063-6394a90a349f | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | American Health Packaging | 937ea2ca-6b8c-4c80-9926-f4de7c8f5643 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Lupin Pharmaceuticals, Inc. | 43e2b0f3-cf34-4f51-aa93-39ed98cab449 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | AvPAK | ee8df8fa-d08a-8c8b-f048-813e5022a101 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | PHOENIX RX LLC | 3ede6724-d9be-5b44-e063-6294a90afbaa | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Cipla USA Inc. | bb83cd61-0a82-4fe0-b72e-5b715cbd656d | 2025-09-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | PHOENIX RX LLC | 3b1938e5-7a9e-b214-e063-6394a90a1270 | 2025-08-13 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| XIFYRM | MELOXICAM | Azurity Pharmaceuticals, Inc. | bf2b198c-0726-488a-b911-4fe394e4b56e | 2025-06-18 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | ANI Pharmaceuticals, Inc. | ce9a8fd7-9bd2-4793-82f3-0fb8f0965d0f | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Asclemed USA, Inc. | 6d7ede5a-c12e-4979-a47a-f3346ea5bc80 | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Carlsbad Technology, Inc. | 20871c7f-1e36-49ef-8e2b-70112430ca1e | 2025-05-02 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | d3182622-4b9b-4850-bf9f-108c5610eb40 | 2025-04-01 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | ed9c8c21-1d08-4afa-9cd2-3fd8b2a83baf | 2025-03-31 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 75af3e09-f510-45a4-9f21-50bff7aa5510 | 2025-03-21 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 218e71c6-265a-45f4-b660-5c1da5a36bd2 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| Meloxicam | MELOXICAM | Aurobindo Pharma Limited | d5e12448-1ca1-46a4-8de4-e8b94567e5a8 | 2025-03-15 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| MELOXICAM | MELOXICAM | Aphena Pharma Solutions - Tennessee, LLC | 2eaac8b2-d50a-a0bc-e063-6294a90a7cac | 2025-02-21 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | A-S Medication Solutions | 29974b41-68b4-42cf-8835-18ae480c2952 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
| meloxicam | MELOXICAM | Asclemed USA, Inc. | 4dc34489-cbb6-4e57-a2cc-a274209456f3 | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | VG2QF83CGL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.